The novel ATR inhibitor VE-821 increases sensitivity of pancreatic cancer cells to radiation and chemotherapy. (2012)

First Author: Prevo R
Attributed to:  Molecular determinants of Radiosensitivity funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.4161/cbt.21093

PubMed Identifier: 22825331

Publication URI: http://europepmc.org/abstract/MED/22825331

Type: Journal Article/Review

Volume: 13

Parent Publication: Cancer biology & therapy

Issue: 11

ISSN: 1538-4047